Bionano Genomics, Inc 10-Q for FY2026 Q3
Bionano Genomics, Inc. (BNGO)
10-Q
2026-11-10
For: 2026-09-30
View Original
Added on
November 10, 2026
About this 10-Q
Bionano Genomics, Inc filed this 10-Q on November 10, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Bionano Genomics reported revenue of $23.1 million, up 13%, and a $22.2 million net loss for the nine months ended September 30, 2026. It faces substantial doubt about going concern and expects additional capital in the very near term. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.28M
- up 12.3% from $7.37M a year earlier
- Net loss
- $6.45M
- compared with a net loss of $8.5M a year earlier
- Diluted EPS
- -$0.54
- compared with -$1.59 a year earlier